BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 19111076)

  • 1. Prognostic Differences Between Surveillance and Active Treatment After Initial Orchiectomy in Patients With Stage I Mixed Germ Cell Tumors of the Testis: A Propensity Score Matching Analysis.
    Du Y; Liu L; Zou B; Chen Z; Chen Q; Deng R; Yang P
    J Surg Res; 2024 Feb; 294():26-36. PubMed ID: 37857140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Systematic Review Investigating the Difference between 1 Cycle versus 2 Cycles of Adjuvant Chemotherapy in Stage I Testicular Germ Cell Cancers.
    Rohozneanu EF; Deac C; Căinap CI
    Medicina (Kaunas); 2023 May; 59(5):. PubMed ID: 37241148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intratumoral heterogeneity and chemoresistance in nonseminomatous germ cell tumor of the testis.
    Bilen MA; Hess KR; Campbell MT; Wang J; Broaddus RR; Karam JA; Ward JF; Wood CG; Choi SL; Rao P; Zhang M; Naing A; General R; Cauley DH; Lin SH; Logothetis CJ; Pisters LL; Tu SM
    Oncotarget; 2016 Dec; 7(52):86280-86289. PubMed ID: 27861143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Late Relapse of Germ Cell Tumors After Prior Chemotherapy or Surgery-only.
    Richardson NH; Althouse SK; Ashkar R; Cary C; Masterson T; Foster RS; Einhorn LH; Adra N
    Clin Genitourin Cancer; 2023 Aug; 21(4):467-474. PubMed ID: 37088659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk analysis of subsequent therapies after first-line chemotherapy in advanced testicular cancer patients.
    Yen TH; Wang SS; Yang CK; Lu K; Chen CS; Cheng CL; Hung SC; Chiu KY; Chen CP; Yang CR; Li JR
    J Chin Med Assoc; 2023 Jul; 86(7):646-652. PubMed ID: 37191945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical characteristics and treatment outcomes of germ cell tumor in Jordan: A tertiary center experience.
    El-Achkar A; Alasadi H; El-Asmar J; Armache A; Abu-Hijlih R; Abu-Hijle F; Al-Ibraheem A; Khzouz J; Salah S; Shahait M
    Arab J Urol; 2023; 21(4):233-239. PubMed ID: 38178954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stage I nonseminomatous germ cell tumor of the testis: more questions than answers?
    Powles T
    Hematol Oncol Clin North Am; 2011 Jun; 25(3):517-27,viii. PubMed ID: 21570606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of patients with low-stage nonseminomatous germ cell testicular cancer.
    Stephenson AJ; Sheinfeld J
    Curr Treat Options Oncol; 2005 Sep; 6(5):367-77. PubMed ID: 16107240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized phase III trial comparing retroperitoneal lymph node dissection with one course of bleomycin and etoposide plus cisplatin chemotherapy in the adjuvant treatment of clinical stage I Nonseminomatous testicular germ cell tumors: AUO trial AH 01/94 by the German Testicular Cancer Study Group.
    Albers P; Siener R; Krege S; Schmelz HU; Dieckmann KP; Heidenreich A; Kwasny P; Pechoel M; Lehmann J; Kliesch S; Köhrmann KU; Fimmers R; Weissbach L; Loy V; Wittekind C; Hartmann M;
    J Clin Oncol; 2008 Jun; 26(18):2966-72. PubMed ID: 18458040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative Effectiveness of Risk-adapted Surveillance vs Retroperitoneal Lymph Node Dissection in Clinical Stage I Nonseminomatous Germ Cell Testicular Cancer: A Retrospective Follow-up Study of 81 Patients.
    Fan G; Zhang L; Yi L; Jiang ZQ; Ke Y; Wang XS; Xiong YY; Han WQ; Zhou X; Liu C; Yu X
    Asian Pac J Cancer Prev; 2015; 16(8):3267-72. PubMed ID: 25921130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Efficacy of modified retroperitoneal lymph node dissection for testicular nonseminomatous germ cell tumors].
    Liu ZW; Zhou FJ; Han H; Qin ZK; Yu SL; Li YH; Ye YL; Teng XY
    Ai Zheng; 2008 Dec; 27(12):1302-6. PubMed ID: 19079998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term oncological outcome after post-chemotherapy retroperitoneal lymph node dissection in men with metastatic nonseminomatous germ cell tumour.
    Fléchon A; Tavernier E; Boyle H; Meeus P; Rivoire M; Droz JP
    BJU Int; 2010 Sep; 106(6):779-85. PubMed ID: 20089110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical outcomes in patients with stage I non-seminomatous germ cell cancer.
    Lv ZJ; Wu S; Dong P; Yao K; He YY; Gui YT; Zhou FJ; Liu ZW; Cai ZM
    Asian J Androl; 2013 Jul; 15(4):558-63. PubMed ID: 23685909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term clinical outcome in patients with stage-I nonseminomatous germ cell cancer. A critical review of own treatment modalities in a retrospective study.
    Seseke S; Bierwirth S; Strauss A; Ringert RH; Seseke F
    Int Braz J Urol; 2008; 34(6):715-22; discussion 723-4. PubMed ID: 19111076
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.